Zdrowie i gospodarka · 19/12/1996

FDA Corrects Final Rule on Blood Manufacturing Practices Due to Incorrect Effective Date

The Food and Drug Administration (FDA) is correcting a final rule on current good manufacturing practices for blood and blood components, which was published with an incorrect effective date in the Federal Register on September 9, 1996, and was intended to address consignees receiving blood and blood components at increased risk for transmitting HIV infection.